Hybrid Conferencee

International Conference on Tumor Immunometabolism and Cancer Therapy (ICTIMCT - 26)

12th - 13th November 2026 | Bucharest, Romania

10% DISCOUNT

Maximum discount capped at $30. Activate your Scholarly Discount during the payment phase to lower your final checkout amount.

REVEAL OFFER
EARLY10
Sample Abstract
Download
Conference Brochure
Sample Full Paper
Download
Conference Notifications:

"Be sure to check this section regularly for all Research Plus International Conference updates. We’ll keep you informed about deadlines, event details, and more important notifications."

Call for Papers Extended:
"The deadline for full paper submissions has been extended for the Research Plus International Conference in Bucharest. Submit your research by today to participate in one of the top conferences."
Certificate of Presentation:
"Present your research and receive a Certificate of Presentation to recognise your valuable contribution to the conference."
Abstract Submissions Open:
"Abstract submissions for the Bucharest event are now open! Don’t miss the chance to present your research. Submit now."
Networking with Global Experts:
"Engage with researchers and professionals from around the world at the Bucharest conference. Build collaborations and gain insights from leading experts."
Keynote Speaker Sessions:
"Don’t miss our Keynote Sessions in Bucharest, featuring global leaders and innovators sharing their knowledge."
Best Paper & Best Paper Presentation Award:
"Submit your paper and stand a chance to win the Best Paper Presentation Award. The winner will be recognized at the conference in Bucharest."
SDG-Inspired Conference Focus:
"Our conference will highlight research that addresses global sustainability, inclusive education, and solutions for environmental challenges."

Conference Session Tracks

SDG Wheel

Aligned with

UN Sustainable Development Goals

This conference contributes to global sustainability by aligning its research discussions and academic sessions with key United Nations Sustainable Development Goals. It fosters knowledge exchange, innovation, and collaborative engagement.

SDG 3
SDG 3 Good Health and Well-being
SDG 4
SDG 4 Quality Education
SDG 9
SDG 9 Industry, Innovation and Infrastructure
Track 01

Immunometabolic Pathways in Tumor Progression

This session will explore the intricate immunometabolic pathways that influence tumor progression and metastasis. Researchers will present novel findings on how metabolic alterations in tumors affect immune cell behavior and tumor microenvironment dynamics.

Track 02

Metabolic Regulation of Immune Cell Function

This track will focus on the role of metabolic regulation in modulating immune cell functions within the tumor microenvironment. Discussions will include how metabolic pathways can be targeted to enhance anti-tumor immunity.

Track 03

Translational Approaches in Cancer Immunotherapy

This session will highlight innovative translational research aimed at bridging the gap between basic immunometabolism studies and clinical application in cancer immunotherapy. Presentations will cover recent advancements in therapeutic strategies that manipulate metabolic pathways to improve patient outcomes.

Track 04

Tumor Microenvironment and Immune Metabolism

This track will delve into the complex interactions between the tumor microenvironment and immune metabolism. Researchers will discuss how tumor-associated factors influence immune cell metabolism and the implications for cancer therapy.

Track 05

Metabolic Signaling in Cancer Cells and Immune Interactions

This session will examine the role of metabolic signaling pathways in cancer cells and their interactions with immune cells. The focus will be on understanding how these signaling networks can be targeted to enhance therapeutic efficacy.

Track 06

Emerging Biomarkers in Immunometabolism

This track will explore the identification and validation of emerging biomarkers related to immunometabolism in cancer. Presentations will discuss their potential utility in predicting treatment responses and patient prognosis.

Track 07

Targeting Metabolic Pathways for Cancer Therapy

This session will focus on novel strategies for targeting metabolic pathways as a means to enhance cancer therapy. Researchers will present preclinical and clinical data on the efficacy of metabolic inhibitors in combination with immunotherapeutic agents.

Track 08

Role of Gut Microbiome in Tumor Immunometabolism

This track will investigate the influence of the gut microbiome on tumor immunometabolism and immune responses. Discussions will include how microbiome modulation can affect cancer therapy outcomes.

Track 09

Metabolic Adaptations in Cancer Immunology

This session will address the metabolic adaptations that occur in immune cells within the tumor context. Presentations will highlight how these adaptations can be exploited to improve immunotherapeutic strategies.

Track 10

Integrative Approaches in Cancer Metabolism Research

This track will focus on integrative approaches that combine genomics, proteomics, and metabolomics to study cancer metabolism. Researchers will share insights on how these multidisciplinary strategies can lead to novel therapeutic targets.

Track 11

Clinical Implications of Immunometabolism in Oncology

This session will discuss the clinical implications of immunometabolism research in oncology practice. Topics will include the integration of immunometabolic insights into personalized cancer treatment regimens.